-
Moleculin Biotech Inc (NASDAQ: MBRX) shares
surged 28 percent to $1.37 after the company reported that its AML treatment liposomal annamycin has been awarded the FDA
Orphan Drug designation.
-
Innocoll Holdings PLC (NASDAQ: INNL) shares rose
22.9 percent to $1.29.
-
Interpace Diagnostics Group Inc (NASDAQ: IDXG)
shares gained 16.3 percent to $2.85 on volume.
-
Cleantech Solutions International Inc (NASDAQ: CLNT) shares surged 14.3 percent to $3.03.
-
Sunshine Heart Inc (NASDAQ: SSH) shares rose 12.4
percent to $2.31. Sunshine Heart shares have surged 107.07 percent over the past 52 weeks, while the S&P 500 index has
gained 14.35 percent in the same period.
-
bebe stores, inc. (NASDAQ: BEBE) shares climbed
11.5 percent to $3.98 after dropping 44.65 percent on Tuesday.
-
Duluth Holdings Inc (NASDAQ: DLTH) shares jumped
11.1 percent to $21.41 after the company reported upbeat Q4 results.
-
Idera Pharmaceuticals Inc (NASDAQ: IDRA) shares
rose 10.5 percent to $2.31. JMP Securities initiated coverage on Idera Pharmaceuticals with a Market Outperform rating.
-
Snap Inc (NYSE: SNAP) gained 6.5 percent to $21.71.
Drexel Hamilton initiated coverage on Snap with a Buy rating.
-
Steelcase Inc. (NYSE: SCS) shares climbed 5.1
percent to $16.40. Steelcase reported Q4 earnings of $0.21 per share on revenue of $769.1 million.
-
Pulmatrix Inc (NASDAQ: PULM) shares gained 5.1
percent to $4.08 after surging 39.57 percent on Tuesday.
-
AdCare Health Systems, Inc. (NYSE: ADK) rose 5.1
percent to $1.23. AdCare Health is expected to report Q4 financial results on March 24, 2017.
-
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) rose
4.8 percent to $8.77 after dropping 4.67 percent on Tuesday.
-
Petroleo Brasileiro SA Petrobras (ADR) (NYSE: PBR)
gained 3 percent to $9.07. Credit Suisse upgraded Petrobras from Neutral to Outperform.
-
Winnebago Industries, Inc. (NYSE: WGO) shares rose 2
percent to $28.35 after the company reported better-than-expected results for its second quarter.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.